T lymphocyte responses to nonpolymorphic HLA-derived peptides are associated with chronic renal allograft dysfunction

Transplantation

Volumn 91, Issue 3, 2011, Pages 279-286

  Smith, Helen J ^a,b   Hanvesakul, Rajesh ^a,b   Bentall, Andrew ^a,b   Shabir, Shazia ^a,b   Morgan, Matthew D ^a,b   Briggs, David ^c   Cockwell, Paul ^a,b   Borrows, Richard ^a,b   Larché, Mark ^d   Ball, Simon ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Autologous peptides; Chronic allograft dysfunction; HLA

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INTERLEUKIN 7 RECEPTOR;

ADULT; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFERON PRODUCTION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SEQUENCE HOMOLOGY; T LYMPHOCYTE;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPES; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDES; RENAL INSUFFICIENCY; TRANSPLANTATION, HOMOLOGOUS;

EID: 79951497009     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318203862d     Document Type: Review

References (38)

1. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289.
2. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005; 16: 3015.
3. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16: 2804.
4. Waanders MM, Heidt S, Koekkoek KM, et al. Monitoring of indirect allorecognition: Wishful thinking or solid data? Tissue Antigens 2008; 71: 1.
5. Vella JP, Spadafora-Ferreira M, Murphy B, et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64: 795.
6. Ciubotariu R, Liu Z, Colovai AI, et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998; 101: 398.
7. Najafian N, Salama AD, Fedoseyeva EV, et al. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: Potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002; 13: 252.
8. Baker RJ, Hernandez-Fuentes MP, Brookes PA, et al. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy. JIm-munol2001; 167: 7199.
9. Poggio ED, Clemente M, Riley J, et al. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. J Am Soc Nephrol 2004; 15: 1952.
10. Bestard O, Nickel P, Cruzado JM, et al. Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol 2008; 19: 1419.
11. Iacomini J, Sayegh MH. Measuring T cell alloreactivity to predict kidney transplant outcomes: Are we there yet? J Am Soc Nephrol 2006; 17: 328.
12. Sawitzki B, Pascher A, Babel N, et al. Can we use biomarkers and functional assays to implement personalized therapies in transplantation? Transplantation 2009; 87: 1595.
13. Poggio ED, Augustine JJ, Clemente M, et al. Pretransplant cellular al-loimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation 2007; 83: 847.
14. Augustine JJ, Poggio ED, Heeger PS, et al. Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots. Transplantation 2008; 86: 529.
15. Hanvesakul R, Maillere B, Briggs D, et al. Indirect recognition of T-cell epitopes derived from the alpha 3 and transmembrane domain of HLA-A2. Am J Transplant 2007; 7: 1148.
16. BoisgeraultF, AnosovaNG, TamRC, etal. Induction of T-cell response to cryptic MHC determinants during allograft rejection. Hum Immu-nol2000; 61: 1352.
17. Lovegrove E, Pettigrew GJ, Bolton EM, et al. Epitope mapping of the indirect T cell response to allogeneic class I MHC: Sequences shared by donor and recipient MHC may prime T cells that provide help for alloantibody production. J Immunol 2001; 167: 4338.
18. +IL-7Ralphahigh cell population in solid organ transplant recipients. J Exp Med 2007; 204: 1533.
19. Sercarz EE, Lehmann PV, Ametani A, et al. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993; 11: 729.
20. Zorn E, Miklos DB, Floyd BH, et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 2004; 199: 1133.
21. Glasziou P, Irwig L, Deeks JJ. When should a new test become the current reference standard? Ann Intern Med 2008; 149: 816.
22. He X, Moore J, Shabir S, et al. Comparison of the predictive performance of eGFR formulae for mortality and graft failure in renal transplant recipients. Transplantation 2009; 87: 384.
23. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520.
24. Litjens NH, Huisman M, Baan CC, et al. Hepatitis B vaccine-specific CD4( +) T cells can be detected and characterised at the single cell level: Limited usefulness of dendritic cells as signal enhancers. J Immunol Methods 2008; 330: 1.
25. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology Updates and future directions. Am JTransplant2008; 8:753.
26. Reeve J, Einecke G, Mengel M, et al. Diagnosing rejection in renal transplants: A comparison of molecular- and histopathology-based approaches. Am J Transplant 2009; 9: 1802.
27. Hariharan S, Kasiske B, Matas A, et al. Surrogate markers for long-term renal allograft survival. Am J Transplant 2004; 4: 1179.
28. Moudgil KD, Sercarz EE. Understanding crypticity is the key to revealing the pathogenesis of autoimmunity. Trends Immunol 2005; 26: 355.
29. Ott PA, Dittrich MT, Herzog BA, et al. T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J Clin Immunol 2004; 24: 327.
30. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: Implications for immunotherapy. Nat Rev Immunol 2002; 2: 85.
31. Boros P, Bromberg JS. De novo autoimmunity after organ transplantation: Targets and possible pathways. Hum Immunol2008; 69: 383.
32. Fedoseyeva EV, Zhang F, Orr PL, et al. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 1999; 162: 6836.
33. Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bron-chiolitis in human lung transplants. J Clin Invest 2007; 117: 3498.
34. Womer KL, Stone JR, Murphy B, et al. Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy. J Am Soc Nephrol 2001; 12: 2500.
35. Tambur AR, Bray RA, Takemoto SK, etal. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 2000; 70: 1055.
36. Smyth LA, Herrera OB, Golshayan D, et al. A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Transplantation 2006; 82(1 suppl): S15.
37. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay. Transplantation 2006; 82: 663.
38. Smith HJ, Hanvesakul R, Morgan M, et al. Chronic graft versus host disease is associated with an immune response to autologous HLA-derived peptides. Transplantation 2010; 90: 555.